Immune response to influenza vaccination in community-dwelling Chinese elderly persons

Vaccine

Volumn 24, Issue 25, 2006, Pages 5371-5380

  Hui, S L ^a   Chu, L W ^a   Peiris, J S M ^a   Chan, K H ^a   Chu, D ^b   Tsui, W ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Family Medicine   (Hong Kong)

Author keywords

Chinese; Elderly; Influenza; Vaccination

Indexed keywords

ALBUMIN; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; PLACEBO;

AGED; ALBUMIN BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED HEADACHE; ELDERLY CARE; FEMALE; HEMAGGLUTINATION INHIBITION; HONG KONG; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS B; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; INJECTION SITE SWELLING; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUTRITION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HONG KONG; HUMANS; IMMUNIZATION SCHEDULE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RESIDENCE CHARACTERISTICS; VACCINATION;

EID: 33744513283     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.032     Document Type: Article

References (36)

1. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 17 (1999) 3-10
2. Centre of Disease and Control. Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practices (ACIP). Morbid. Weekly Report; 2004.
3. Sprenger M.J.W., Mulder P.G.H., Beyer W.E.P., Van S.R., and Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 22 (1993) 334-340
4. Perrotta D.M., Decker M., and Glezen W.P. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 122 (1985) 468-476
5. Cox N.J., and Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 51 (2000) 407-421
6. World Health Organization. Adoption on global agenda on influenza. Wkly Epidemiol Rec 77 (2002) 191-195
7. Stephenson I., and Zambon M. The epidemiology of influenza. Occup Med 52 5 (2002) 241-247
8. Couch R.B. Influenza: prospects for control. Ann Intern Med 133 (2000) 992-998
9. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., and Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 9492 (2005) 1165-1174
10. Fitzner K.A., McGhee S.M., Hedley A.J., and Shortridge K.F. Influenza surveillance in Hong Kong: results of a trial Physician Sentinel Programme. Hong Kong Med J 5 (1999) 87-94
11. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 16 (2003) 1780-1785
12. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., et al. Major causes of death among men and women in China. N Engl J Med 353 11 (2005) 1124-1134
13. Department of Health. http://www.info.gov.hk/dh/diseaes/influenza.htm.
14. Hospital Authority. Influenza vaccination for elderly at general outpatient clinics (2004) [press release].
15. Department of Health Annual Report, 2001/2002. http://www.info.gov.hk/dh/ar0002/content.htm.
16. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 8 (2006) 1159-1169
17. Bernstein E., Kaye D., Abrutyn E., Gross P., Dorfman M., and Murasko D.M. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17 (1999) 82-94
18. Beyer W.E.P., Palache A.M., Lüchters G., Nauta J., and Osterhaus A.D.M.E. Seroprotection rate, mean fold increase, serological response rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res 103 (2004) 125-132
19. Beyer W.E.P., Palache A.M., Sprenger M.J.W., Hendriksen E., Tukker J.J., Darioli R., et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 14 (1996) 1331-1339
20. Brandiss M.W., Betts R.F., Mathur U., and Douglas R.G. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1)-A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines. Am Rev Respir Dis 124 (1981) 681-684
21. Breeze E., Mangtani P., Fletcher A.E., Price G.M., Kovats S., and Roberts J. Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: survey of 73 general practices in Britain. BMC Fam Pract 5 (2004) 8
22. Bruijn de I.A., Remarque E.J., Beyer W.E., Cessie le.S., Masurel N., and Ligth G.J. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 15 12-13 (1997) 1323-1329
23. Brydak L.B., Machala M., Mysliwska J., Mysliwski A., and Trzonkowski P. Immune response to influenza vaccination in an elderly population. J Clin Immunol 23 (2003) 214-222
24. Christenson B., Lundbergh P., Hedlund J., and Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 357 (2001) 1008-1011
25. Goodeve A., Potter C.W., Clark A., Jennings R., Schild G.C., and Yetts A. A graded dose study of inactivated surface antigen influenza B vaccine in volunteers. J Hyg Camb 90 (1983) 107-115
26. Govaert T.M.E., Sprenger M.J.W., Dinant G.J., Aretz K., Masurel N., and Knottnerus J.A. Immune response to influenza vaccination of elderly people. A randomized double-blind, placebo-controlled trial. Vaccine 12 13 (1994) 1185-1189
27. Gross P.A., Russo C., Dran S., Cataruozolo P., Munk G., and Lancey S.C. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 4 4 (1997) 491-492
28. Jianping H., Xin F., Changshun L., Bo Z., Linxiu G., Wei X., et al. Assessment of effectiveness of Vaxigrip. Vaccine 17 Suppl. 1 (1999) S57-S58
29. Hara M., Tanaka K., and Hrota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 23 12 (2005) 1457-1463
30. Wick G., and Grubeck-Loebenstein B. Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease. Immunol Rev 160 (1997) 171-184
31. Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol Dec 20 2005 [epub ahead of print].
32. Wong C.M., Chan K.P., Hedley A.J., and Peiris J.S.M. Influenza-associated mortality in Hong Kong. Clin Infect Dis 39 (2004) 1611-1617
33. McElhaney J.E., Herre J.M., Lawson M.L., Cole S.K., Burke B.L., and Hooton J.W. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 22 5-6 (2004) 681-688
34. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., and Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102 25 (2000) 3039-3045
35. Madjid M., Awan I., Ali M., Frazier L., and Casscells W. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther 5 1 (2005) 91-96
36. Chu L.W., and Chu M. A survey on the health and health care needs of elderly people living in Central and Western District (1998), Elite Business Services Ltd.